NUCLEOTIDE PHOSPHATE DISSIPATION AS A TREATMENT FOR VASCULAR DISORDERS
    4.
    发明申请
    NUCLEOTIDE PHOSPHATE DISSIPATION AS A TREATMENT FOR VASCULAR DISORDERS 审中-公开
    磷酸氢钙作为血管疾病的治疗药物

    公开(公告)号:US20090130092A1

    公开(公告)日:2009-05-21

    申请号:US12261870

    申请日:2008-10-30

    IPC分类号: A61K39/395 A61K38/43

    CPC分类号: A61K38/465 C12Y301/03005

    摘要: The present invention provides a method of treating or preventing immunoinflammatory, vascular, thrombotic or ischemic disorders in a subject, the method comprises administering to the subject an agent which dissipates nucleotide phosphates or generates a product which stimulates adenosine receptors. The present invention also provides a method of treating or preventing immunoinflammatory, thrombotic or ischemic disorders in a subject by inhibiting leukocyte infiltration into a site which comprises administering to the subject an effective amount a described agent. Agents described for use in the methods of the invention include CD73, a fragment a mutant, or a modified form thereof.

    摘要翻译: 本发明提供了治疗或预防受试者的免疫炎症,血管,血栓形成或缺血性疾病的方法,所述方法包括向受试者施用耗散磷酸核苷酸或产生刺激腺苷受体的产物的药剂。 本发明还提供了通过抑制白细胞浸润到一个部位来治疗或预防受试者的免疫炎性,血栓形成或缺血性疾病的方法,其包括向受试者施用有效量的所述试剂。 描述用于本发明方法的试剂包括CD73,突变体片段或其修饰形式。